Luxturna

Luxturna (Voretigene Neparvovec) is a gene therapy designed for inherited retinal diseases. This innovative treatment targets specific genetic mutations to potentially restore vision. Learn more about Luxturna's uses and effects.

Luxturna is used for the treatment of inherited retinal diseases caused by mutations in the RPE65 gene. This gene therapy aims to address vision loss by delivering a functional copy of the RPE65 gene to the retina. Patients with confirmed RPE65 mutation-related retinal dystrophy may be candidates for this treatment.

Luxturna works by introducing a functional gene into the retinal cells to potentially improve vision. Common effects may include gradual vision improvement over time, though individual results can vary. Patients should consult their healthcare provider for personalized information.

Luxturna should be administered by healthcare professionals experienced in gene therapy. Patients should discuss their medical history and any current medications with their doctor before treatment. Follow all safety guidelines provided by the healthcare team.

Specific drug interactions for Luxturna are not well-documented, but patients should inform their healthcare provider about all medications they are taking. This includes over-the-counter drugs, supplements, and any other treatments. Always follow the advice of a healthcare professional.